CVD risk factors | Optimal | Suboptimal | Readmission event rate | Â | Abnormal vs Normal | Suboptimal vs Optimal | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Normal test [n (%)] | Abnormal test [n (%)] | No screening [n (%)] | Normal test [n (%)] | Abnormal test [n (%)] | No screening [n (%)] | Â | HR | 95% CI | P value | HR | 95% CI | P value | |
HDL | 816 (15.5%) | 143 (2.7%) | 4297 (81.8%) | 252 (30.9% | 51 (35.7%) | 2023 (47.1%) | Crude | 1.21 | 0.90–1.64 | 0.209 | 1.63 | 1.44–1.84 |  < 0.001c |
Adjusteda | 0.51 | 0.12–2.24 | 0.371 | 1.74 | 1.54–1.97 |  < 0.001c | |||||||
LDL | 624 (11.9%) | 335 (6.4%) | 4297 (81.8%) | 217 (31.4%) | 53 (31.7%) | 2056 (46.7%) | Crude | 0.93 | 0.73–1.18 | 0.530 | 1.63 | 1.44–1.84 |  < 0.001c |
Adjusteda | 0.66 | 0.23–1.89 | 0.439 | 1.74 | 1.54–1.97 |  < 0.001c | |||||||
FGlu | 690 (13.1%) | 167 (3.2%) | 4399 (83.7%) | 1086 (38.7%) | 723 (42.4%) | 517 (69.5%) | Crude | 1.01 | 0.75–1.37 | 0.942 | 1.63 | 1.43–1.85 |  < 0.001c |
Adjusteda | 1.38 | 0.39–4.83 | 0.618 | 1.75 | 1.54–1.99 |  < 0.001c | |||||||
HbA1C | 619 (11.8%) | 188 (3.6%) | 4449 (84.6%) | 320 (47.7%) | 869 (50.1%) | 1137 (39.9%) | Crude | 1.26 | 0.99–1.62 | 0.063 | 1.13 | 1.01–1.27 | 0.036b |
Adjusteda | 12.2 | 2.55–58.38 | 0.002c | 1.10 | 0.97–1.25 | 0.122 | |||||||
SBP | 2808 (53.4%) | 1704 (32.4%) | 744 (14.2%) | 202 (32.4%) | 101 (30.1%) | 2023 (47.1%) | Crude | 1.11 | 1.01–1.22 | 0.024b | 2.37 | 2.15–2.61 |  < 0.001c |
Adjusteda | 1.77 | 0.61–5.15 | 0.295 | 2.07 | 1.87–2.30 |  < 0.001c | |||||||
DBP | 3110 (59.2%) | 1402 (26.7%) | 744 (14.2%) | 239 (38.6%) | 86 (45.7%) | 2001 (45.0%) | Crude | 1.28 | 1.16–1.41 |  < 0.001c | 2.37 | 2.15–2.61 |  < 0.001c |
Adjusteda | 1.07 | 0.36–3.17 | 0.903 | 2.07 | 1.87–2.30 |  < 0.001c | |||||||
BMI | 671 (12.8%) | 1733 (33.0%) | 2852 (54.3%) | 1168 (37.6%) | 641 (45.7%) | 517 (69.5%) | Crude | 1.06 | 0.93–1.21 | 0.363 | 0.75 | 0.69–0.82 |  < 0.001c |
Adjusteda | 0.56 | 0.17–1.87 | 0.347 | 0.92 | 0.85–1.00 | 0.055 |